Bio-Path raises ~$299k in registered direct offering; issues warrants

BIO-PATH HOLDINGS, INC.

Gross proceeds of $299,250 from 75,000 shares at $3.99/share; net ~$0.2M after fees.
Common warrants to purchase up to 75,000 shares at $3.865, 5-year term, immediate exercise.
Placement agent H.C. Wainwright gets 7.5% fee plus warrants for 5,625 shares at $4.9875.
Proceeds for working capital; closing expected March 27, 2024.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BIO-PATH HOLDINGS, INC. entered into Purchase Agreement with an institutional investor valued at gross proceeds of $299,250 (effective 2024-03-25).

Action: entry
Agreement: equity purchase
Counterparty: an institutional investor
Value: gross proceeds of $299,250
Effective: 2024-03-25

Exact text from the filing

On March 25, 2024, Bio-Path Holdings, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with an institutional investor, pursuant to which the Company agreed to sell, in a registered direct offering (the “Registered Direct Offering”), an aggregate of 75,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), for a purchase price per Share of $3.99 and gross proceeds of $299,250.

View on SEC.gov

543 material agreements filed in the last 30 days. Browse all material agreements →

BIO-PATH HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-038742

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.